eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


6/2006
vol. 5
 
Share:
Share:
abstract:

The influence of sequential transdermal hormone therapy on serum hormone and lipids profile in perimenopausal women

Violetta Skrzypulec
,
Wioleta Rozmus-Warcholińska
,
Dariusz Zdun

Przegląd Menopauzalny 2006; 6: 374–381
Online publish date: 2007/02/08
View full text Get citation
 
Aim of the study: The evaluation of the effect of sequential transdermal hormone therapy on serum hormone and lipids profile in perimenopausal women.
Material and methods: In a six-month (6 treatment periods, 28 days each) randomized study, 75 healthy postmenopausal women aged 48-53(51±3) were assigned to receive 50 micrograms/day of continuous transdermal estradiol with sequential transdermal norethisterone acetate (NETA) in daily doses of 170 micrograms for in a single transdermal patch.
Results: Effects on coronary heart disease risk factors, such as reductions in total cholesterol (- 4%; 6±0.9 mmol/l at baseline an 5.9±1.0 mmol/l at the end of the study), low-density lipoprotein cholesterol (-4.6%; 3.7±0.8 mmol/l at baseline and 3.6±0.9 mmol/l after treatment), triglicerydes (-15.4%; 1.6±0.9 mmol/l at baseline and 1.8±1.0 mmol/l after treatment) and significant decrease of high-density lipoprotein cholesterol levels (-17.2%; 1.7±0.4 mmol/l at baseline and 1.4±0.3 mmol/l after treatment) were measured in the treatment group. Nonsignificant dicrease within FSH serum levels (65±33 mIU/ml at baseline and 46±29 mIU/ml at the end of the study) and nonsignificant rise of 17 beta-estradiol (44±81 pg/ml at basleine and 189±236 pg/ml t the end of the study) across treatment were observed.
Conclusions: Sequential transdermal estrogen/progestogen hormone therapy with estradiol/NETA appears to be effective and safe for serum hormone and lipids profile in perimenopausal women.
keywords:

menopause, hormone therapy, serum hormone profile, serum lipid profile

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.